KYMERA THERAPEUTICS INC (KYMR) Stock Balance Sheet
NASDAQ:KYMR - Nasdaq - US5015751044 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 89.97M | 120.26M | 109.97M | 68.40M | 48.00M | |||
| Marketable Securities | 373.18M | 368.49M | 264.92M | 338.80M | 394.40M | |||
| Receivables | 20.00M | 947.00K | 18.76M | 2.50M | 100.00K | |||
| Other Current Assets | 17.80M | 20.58M | 11.67M | 9.70M | 8.70M | |||
| Total Current Assets | 500.95M | 510.27M | 405.32M | 419.40M | 451.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 95.91M | 97.86M | 101.08M | 22.20M | 21.30M | |||
| Investments And Advances | 312.33M | 362.16M | 61.43M | 152.30M | 125.20M | |||
| Other Non-Current Assets | 9.12M | 7.74M | 7.93M | 9.10M | 8.10M | |||
| Total Non-Current Assets | 417.36M | 467.77M | 170.44M | 183.70M | 154.60M | |||
| TOTAL ASSETS | 918.31M | 978.03M | 575.76M | 603.10M | 605.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.56M | 1.52M | 1.28M | 1.40M | 1.10M | |||
| Accrued Expenses | 34.47M | 46.10M | 35.25M | 29.60M | 25.10M | |||
| Accounts Payable | 10.26M | 5.99M | 7.08M | 4.30M | 4.00M | |||
| Other Current Liabilities | 12.70M | 14.15M | 42.09M | 36.00M | 62.30M | |||
| Total Current Liabilities | 58.99M | 67.77M | 85.69M | 71.30M | 92.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.91M | 2.23M | 1.30M | 1.20M | 1.10M | |||
| Other Non-Current Liabilities | 71.18M | 72.42M | 93.80M | 40.40M | 52.60M | |||
| Total Non-Current Liabilities | 73.09M | 74.65M | 95.10M | 41.70M | 53.80M | |||
| TOTAL LIABILITIES | 132.08M | 142.42M | 180.79M | 113.00M | 146.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -820.19M | -754.61M | -530.75M | -383.80M | -229.00M | |||
| Additional Paid In Capital | 1.61B | 1.59B | 926.27M | 878.90M | 689.30M | |||
| Common Shares | 7.00K | 7.00K | 6.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -58.00K | -1.49M | -552.00K | -4.90M | -700.00K | |||
| Shares Outstanding | 65.11M | 64.89M | 55.59M | 55.00M | 51.50M | |||
| Tangible Book Value per Share | 12.07 | 12.88 | 7.11 | 8.91 | 8.92 | |||
| Total Shareholders' Equity | 786.23M | 835.62M | 394.97M | 490.20M | 459.60M | |||
| TOTAL LIABILITIES AND EQUITY | 918.31M | 978.03M | 575.76M | 603.10M | 605.90M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 8.49 | 7.53 | 4.73 | 5.88 | 4.88 | |||
| Return On Assets (ROA) | -26.23% | -22.89% | -25.52% | -25.67% | -16.54% | |||
| Return On Equity (ROE) | -30.64% | -26.79% | -37.21% | -31.58% | -21.81% | |||
All data in USD , ROIC based on taxRate of 0.21